Thanks to the rapid development of vaccines and quick vaccinations in major parts of the world, there seem positive developments in all the business sectors towards the growth. However, the threat is persisting in terms of new waves and new variants of COVID. Let us hope we soon get over this and see the brighter side of the business.
-
-
It is apparent that COVID-19 has permanently changed the ways of business operations for many industries across the globe. In fact, it has subtly given a renewed purpose to industries to evolve and advance in terms of tech-enabled and automated workflows.
-
December 15, 2021 Pharmaceuticals, Regulatory Affairs, Regulatory ConsultingApplicants often misunderstand the scope of the meetings with the Medicines and Healthcare products Regulatory Agency (MHRA) and fail to comply with the legislative requirements of such meetings. These misunderstandings create prejudice against the procedure and affect the success rate of the meetings.
Scientific advice meetings with the MHRA can be held in the following phases.
-
November 3, 2021 PharmaceuticalsInternational Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an international non-profit organization that strives to maintain an updated database to summon Regulatory Agencies and pharmaceutical manufacturers to discuss scientific and technical aspects of the industry on a single platform.
-
October 26, 2021 Pharmaceuticals, Regulatory Affairs, Publishing & SubmissionsChina has established its position as a manufacturing hub for pharmaceuticals. Innovation in manufacturing techniques has encouraged China to explore the scope of research and development for medicinal preparations.
-
September 20, 2021 Pharmaceuticals, Regulatory AffairsRecently, the Director-general – NAFDAC announced the commencement of a Sensitization Campaign in Nigeria. Through this campaign, NAFDAC intends to inform, sensitize and educate the Nigerian citizens about the dangers of intake and use of bogus medicinal products surfacing the market.
-
August 26, 2021 Regulatory LabelingCommunication effectiveness across the marketing platforms is evaluated primarily based on how well the content engages the audience or, in the case of brands, the consumer. In healthcare, the information available on these platforms is diverse.
-
March 30, 2021 Pharmaceuticals, Regulatory AffairsANVISA of Brazil received the approval to become a member of PIC/s (Pharmaceutical Inspection Co-operation Scheme) in November 2020. Considering the pandemic situation, for the first time in PIC/s history, the assessment was completed in a written procedure as opposed to at a meeting; on Jan 1, 2021, the PIC/s committee welcomed ANVISA as their 54th valuable member.
-
February 9, 2021 Pharmaceuticals, Medical Devices, Food and Food Supplements, Chemicals, Consumer Healthcare, Regulatory AffairsThe year 2020 has been unpredictable for all the industries across the globe, including life sciences industry. With the outbreak of COVID-19, the life sciences industry and global Health Authorities faced various challenging scenarios, which in turn affected their long-term Regulatory plans.
-
The year 2020 was a roller coaster for everyone across the world. With the outbreak of the COVID-19, global Health Authorities (HAs) have been working relentlessly to ensure that healthcare professionals and the general public have the best resources to fight this pandemic.